Literature DB >> 29665559

Semistructured Interview for Bipolar At Risk States (SIBARS).

Paolo Fusar-Poli1, Andrea De Micheli2, Matteo Rocchetti2, Marco Cappucciati2, Valentina Ramella-Cravaro2, Grazia Rutigliano2, Ilaria Bonoldi2, Philip McGuire3, Irina Falkenberg4.   

Abstract

The external prognostic accuracy of Bipolar At Risk (BAR) criteria is undetermined and no psychometric tools are available to measure them. We present here three studies that overcome these limitations. Study 1 and 2 investigated the prognostic accuracy (Harrell's C) of the original BAR and revised Bipolar At Risk States (BARS) criteria respectively for the prediction of bipolar disorders, using a retrospective cohort of individuals at Clinical High Risk for Psychosis (CHR-P). Study 3 validated externally the prognostic accuracy of a newly developed Semistructured Interview of At Risk Bipolar States (SIBARS) in an independent prospective CHR-P cohort. In study 1 (n = 205), those meeting BAR criteria had an increased risk of developing bipolar disorders (HR = 5.30) relative to those not meeting them, but the prognostic accuracy was poor (Harrell's C = 0.659). In study 2 (n = 205), those meeting the refined BARS criteria had a higher risk of developing bipolar disorders than those not meeting them (HR = 12.364), with an adequate prognostic accuracy (Harrell's C = 0.777). Study 3 (n = 71) confirmed that SIBARS criteria had an adequate prognostic accuracy (Harrell's C = 0.742) and clinical utility. Overall, these findings suggest that the SIBARS could be used for the detection of individuals at risk of developing bipolar disorders in CHR-P services.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29665559     DOI: 10.1016/j.psychres.2018.03.074

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

1.  Prognostic Accuracy of DSM-5 Attenuated Psychosis Syndrome in Adolescents: Prospective Real-World 5-Year Cohort Study.

Authors:  Martina Maria Mensi; Silvia Molteni; Melanie Iorio; Eleonora Filosi; Elena Ballante; Umberto Balottin; Paolo Fusar-Poli; Renato Borgatti
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 9.306

2.  Preventive psychiatry: a blueprint for improving the mental health of young people.

Authors:  Paolo Fusar-Poli; Christoph U Correll; Celso Arango; Michael Berk; Vikram Patel; John P A Ioannidis
Journal:  World Psychiatry       Date:  2021-06       Impact factor: 79.683

3.  Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence).

Authors:  Paolo Fusar-Poli; Cathy Davies; Marco Solmi; Natascia Brondino; Andrea De Micheli; Magdalena Kotlicka-Antczak; Jae Il Shin; Joaquim Radua
Journal:  Front Psychiatry       Date:  2019-12-11       Impact factor: 4.157

4.  Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife).

Authors:  Andrea Pfennig; Karolina Leopold; Julia Martini; Anne Boehme; Martin Lambert; Thomas Stamm; Felix Bermpohl; Andreas Reif; Sarah Kittel-Schneider; Georg Juckel; Andreas J Fallgatter; Tilo Kircher; Andreas Jansen; Steffi Pfeiffer; Christina Berndt; Maren Rottmann-Wolf; Cathrin Sauer; Philipp Ritter; Christoph U Correll; Andreas Bechdolf; Irina Falkenberg; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2020-07-01

Review 5.  Establishing a clinical service to prevent psychosis: What, how and when? Systematic review.

Authors:  Gonzalo Salazar de Pablo; Andrés Estradé; Marcello Cutroni; Olivier Andlauer; Paolo Fusar-Poli
Journal:  Transl Psychiatry       Date:  2021-01-13       Impact factor: 6.222

6.  Individuals at increased risk for development of bipolar disorder display structural alterations similar to people with manifest disease.

Authors:  Pavol Mikolas; Kyra Bröckel; Christoph Vogelbacher; Dirk K Müller; Michael Marxen; Christina Berndt; Cathrin Sauer; Stine Jung; Juliane Hilde Fröhner; Andreas J Fallgatter; Thomas Ethofer; Anne Rau; Tilo Kircher; Irina Falkenberg; Martin Lambert; Vivien Kraft; Karolina Leopold; Andreas Bechdolf; Andreas Reif; Silke Matura; Thomas Stamm; Felix Bermpohl; Jana Fiebig; Georg Juckel; Vera Flasbeck; Christoph U Correll; Philipp Ritter; Michael Bauer; Andreas Jansen; Andrea Pfennig
Journal:  Transl Psychiatry       Date:  2021-09-20       Impact factor: 6.222

7.  Alterations in blood proteins in the prodromal stage of bipolar II disorders.

Authors:  Hyunju Lee; Dohyun Han; Sang Jin Rhee; Jayoun Kim; Yunna Lee; Eun Young Kim; Dong Yeon Park; Sungwon Roh; Myungjae Baik; Hee Yeon Jung; Junhee Lee; Tae Young Lee; Minah Kim; Hyunsuk Shin; Hyeyoon Kim; Se Hyun Kim; Jun Soo Kwon; Yong Min Ahn; Kyooseob Ha
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

8.  Early detection of bipolar disorders and treatment recommendations for help-seeking adolescents and young adults: Findings of the Early Detection and Intervention Center Dresden.

Authors:  Julia Martini; Karolina Leopold; Steffi Pfeiffer; Christina Berndt; Anne Boehme; Veit Roessner; Paolo Fusar-Poli; Allan H Young; Christoph U Correll; Michael Bauer; Andrea Pfennig
Journal:  Int J Bipolar Disord       Date:  2021-07-02

9.  Study Protocol for a Prospective Longitudinal Cohort Study to Identify Proteomic Predictors of Pluripotent Risk for Mental Illness: The Seoul Pluripotent Risk for Mental Illness Study.

Authors:  Tae Young Lee; Junhee Lee; Hyun Ju Lee; Yunna Lee; Sang Jin Rhee; Dong Yeon Park; Myung Jae Paek; Eun Young Kim; Euitae Kim; Sungwon Roh; Hee Yeon Jung; Minah Kim; Se Hyun Kim; Dohyun Han; Yong Min Ahn; Kyooseob Ha; Jun Soo Kwon
Journal:  Front Psychiatry       Date:  2020-04-21       Impact factor: 4.157

10.  Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis.

Authors:  Paolo Fusar-Poli; Thomas Spencer; Andrea De Micheli; Victoria Curzi; Sunil Nandha; Philip McGuire
Journal:  Eur Neuropsychopharmacol       Date:  2020-09-10       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.